The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Recently, we reported that angiopoietin-like protein 2 (Angptl2) functions in various chronic inflammatory diseases. In the present study, we asked whether Angptl2 and its associated chronic inflammation contribute to abdominal aortic aneurysm (AAA). Methods and Results-Immunohistochemistry revealed that Angptl2 is abundantly expressed in infiltrating macrophages within the vessel wall of patients with AAA and in a CaCl 2 -induced AAA mouse model. When Angptl2-deficient mice were used in the mouse model, they showed decreased AAA development compared with wild-type mice, as evidenced by reduction in aneurysmal size, less severe destruction of vessel structure, and lower expression of proinflammatory cytokines and matrix metalloproteinase-9. However, no difference in the number of infiltrating macrophages within the aortic aneurysmal vessel wall was observed between genotypes. AAA development was also significantly suppressed in wild-type mice that underwent Angptl2-deficient bone marrow transplantation. Expression levels of proinflammatory cytokines and metalloproteinase-9 in Angptl2-deficient macrophages were significantly decreased, and those decreases were rescued by treatment of Angptl2 deficient macrophages with exogenous Angptl2.
A bdominal aortic aneurysm (AAA) is a major cause of death among men aged over 65 years in more developed countries. 1 AAA incidence has increased during the past 2 decades, in part, because of increases in the number of older subjects and smokers. [2] [3] [4] [5] [6] AAA is clinically diagnosed as either a 1.5-fold increase in aortic diameter compared with normal adjacent aorta or an aneurysm with a diameter exceeding 30 mm. 7 AAA usually shows slow progression, but the condition tends to be asymptomatic until the time of aortic rupture. The overall mortality rate for patients with ruptured AAAs exceeds 80%, and about half of the deaths attributed to rupture occur before the patient reaches the surgical room. Because many patients with AAA are at high risk for rupture at the time of initial diagnosis, early diagnosis is important to allow patients the option of undergoing elective surgery. Worldwide surgical consensus suggests that an aortic aneurysm with a diameter exceeding 55 mm should be repaired, 8 and that early surgical therapy for small aortic aneurysms has no benefit. 9 AAA shows variable growth rates between individuals, making it difficult to predict optimal surgical intervention time. Therefore, early diagnosis and close clinical observation of patients with AAA are required to follow disease progression.
Although both diagnostic and therapeutic strategies for AAA have improved, 10, 11 interventions to reduce and inhibit AAA progression have not been successful, in part, because of a lack of understanding of mechanisms underlying the process. Aortic diameter is a major predictor of AAA rupture. Therefore, nonsurgical therapy to decrease AAA diameter would be desirable to reduce risk of rupture. AAA is characterized pathologically by atherosclerotic changes with chronic inflammation characterized by infiltrating inflammatory cells, such as neutrophils, T cells, B cells, macrophages, and mast cells. 12, 13 Infiltrating cells persistently secrete inflammatory cytokines and chemokines, resulting in chronic inflammation of the aortic wall. 14 Recent studies reveal that infiltrating macrophages in aortic aneurysmal vessel walls release matrix metalloproteinases (MMPs), particularly MMP-9, 15 resulting in extracellular matrix (ECM) degradation and AAA progression attributable to destructive remodeling of elastic media and of the outer aortic wall. Thus, AAA progression is considered irreversible and destructive, emphasizing the need to devise ways to inhibit chronic inflammation and subsequent ECM degradation in the aortic wall.
Recently, we found that angiopoietin-like protein 2 (Angptl2) is an important inflammatory mediator of various chronic diseases, such as metabolic disorders in obesity, 16 rheumatoid arthritis, 17 and cancer. 18 In these pathologies, Angptl2 is abundantly expressed in infiltrating macrophages, 16, 17 which are often detected in aortic aneurysmal walls. Here, we used mice genetically deficient in Angptl2 to determine whether Angptl2 and its associated chronic inflammation contribute to AAA development.
Methods
Some of the procedures are provided in this section. An expanded description of other remaining materials and methods used for these studies is available in the online-only Data Supplement.
Animals
Angptl2-deficient (Angptl2 −/− ) male mice and littermate wild-type male mice on a C57BL/6N (Kyudo Co, Ltd, Saga, Japan) background were used for all experiments as described. 16 Animals were bred in a mouse house with automatically controlled lighting (12 hours on, 12 hours off), and a stable temperature of 23°C was maintained throughout. Mice were fed a normal diet (CE-2, CLEA Japan, Tokyo, Japan). All procedures were approved by the Kumamoto University Ethics Review Committee for Animal Experimentation.
AAA Mouse Model
We induced AAA in 10-to 12-week-old mice by periaortic application of 0.75 M CaCl 2 as described. 19 On day 28 after operation, we excised the abdominal aorta, photographed tissues to determine aortic diameters, and then examined tissues by quantitative reverse transcription polymerase chain reaction (RT-PCR) and histological analyses. Aortic diameter data were quantified using computer-assisted image analysis software ImageJ (National Institutes of Health freeware). All aortic morphometry was performed by investigators blinded to experimental groups. Angptl2 protein expression in CaCl 2 -induced AAA lesions of wild-type and Angptl2 −/− mice was investigated as shown in Figure II in the online-only Data Supplement.
Bone Marrow Transplantation
Mouse bone marrow (BM) transplantation procedures have been described. 20 In brief, wild-type or Angptl2 −/− recipient mice underwent 9 Gy total body irradiation to eradicate BM cells, and then received BM cells from wild-type or Angptl2 −/− mice intravenously. Seven days after BM transplantation, recipient mice were treated with CaCl 2 treatment to generate AAA model.
Results

Angptl2 Is Expressed in Macrophages Within Aortic Aneurysmal Walls of Patients With AAA
To investigate a potential role for Angptl2 in AAA formation, we used quantitative RT-PCR and immunohistochemical analyses to determine whether aortic aneurysmal lesion tissues from patients with AAA express Angptl2. RT-PCR analysis revealed that Angptl2 mRNA expression in aortic aneurysmal lesions was significantly increased compared with that seen in nondilating aorta surrounding lesions ( Figure 1A ). Aortic aneurysmal lesion inflammatory status was also markedly enhanced relative to nondilating aorta tissue surrounding lesions based on quantitative RT-PCR analysis of the proinflammatory markers, tumor necrosis factor- (TNF-), interleukin-1 (IL-1), and IL-6 ( Figure 1A ). Significantly increased expression of MMP-2 and MMP-9, as estimated by RT-PCR analysis ( Figure 1B) , and increased MMP-2 and MMP-9 activity, as estimated by zymography ( Figure 1C ), in aortic aneurysmal lesions were observed compared with effects seen in nondilating aorta surrounding the lesions, suggesting enhanced ECM degradation in the vessel wall of the aortic aneurysmal lesion. Histological analysis using Elastica van Gieson staining revealed destruction of medial elastic fibers at aortic aneurysmal lesions (arrowheads in Figure 1E ), whereas vessel structure was preserved at nondilating aorta surrounding lesions (arrowheads in Figure 1D ). Immunohistochemical staining revealed numerous CD68-positive macrophages infiltrating the medial layer of aortic aneurysmal lesions, whereas few were observed at nondilating aorta ( Figure 1D and 1E). HHF35-positive smooth muscle cells, which maintain vessel structure, were seen in the medial layer of nondilating lesions, whereas aortic aneurysmal lesions exhibited a disorganized medial layer depleted of smooth muscle cells ( Figure 1D and 1E). These findings indicate that AAA tissues exhibit characteristics of chronic inflammation and are characterized by destructive cell remodeling in the abdominal aortic wall. Notably, immunohistochemistry of serial tissue sections stained with an anti-Angptl2 antibody revealed Angptl2-positive cells localized primarily at the medial layer of aortic aneurysmal lesions in a pattern similar to that of the macrophage marker CD68 ( Figure 1E ; Figure IA in the online-only Data Supplement). Double immunofluorescence staining of AAA tissues was performed using antibodies against Angptl2 and markers of specific cell lineages followed by confocal microscopy. At the medial layer of aortic aneurysmal lesions, CD68-expressing cells, but not CD20-, CD3-, or CD15-expressing cells, coexpressed Angptl2 ( Figure 1F ; Figure IB in the online-only Data Supplement). These results indicate that Angptl2 is produced primarily in infiltrating macrophages, but not in B and T lymphocytes and neutrophils, at aortic aneurysmal lesions of human AAA walls, suggesting that macrophage-derived Angptl2 functions in lesion formation.
Angptl2 Is Expressed in Infiltrating Macrophages in a CaCl 2 -Induced AAA Mouse Model
Next, we asked whether Angptl2 contributes to pathogenesis seen in a CaCl 2 -induced AAA mouse model (Figure 2A) . To create the model, we treated the abdominal aorta of wild-type mice with CaCl 2 and then analyzed AAA development 28 days later. In our AAA mouse model, we observed no death during the experimental observation period as a result of aortic rupture after CaCl 2 treatment. We observed significant dilatation of the abdominal aorta, whereas few changes in the abdominal aorta were observed with saline-treated, sham-operated, controls ( Figure 2B ). Quantitative aortic morphometric analysis showed a significantly increased aortic diameter of CaCl 2 -induced aneurysms compared with that seen in saline-treated sham-operated control aorta ( Figure 2B ). Expression of TNF-, IL-1, and IL-6 mRNAs in CaCl 2 -treated aortic lesion tissues was markedly increased compared with sham-operated mice ( Figure 2C ), indicating that inflammation had occurred by day 28 after treatment. Furthermore, Angptl2 expression levels were significantly increased compared with those seen in the sham-operated group (Figure 2E ), as was expression of MMP-9 and MMP-2 mRNA ( Figure 2D ), suggesting that Angptl2 contributes to the pathogenesis in this model. Immunohistochemistry with an anti-Ang-ptl2 antibody revealed that Angptl2-positive cells were localized primarily at the medial layer of aortic aneurysm in the CaCl 2 treatment group, whereas few Angptl2-positive cells were seen in the aorta from sham-operated mice ( Figure 2F ). Because Angptl2 is produced primarily in infiltrating macrophages at aortic aneurysmal lesions in human AAA walls ( Figure 1E and 1F), we asked whether Angptl2-positive cells at the medial layer of aortic aneurysms in the CaCl 2 treatment group were macrophages based on immunohistochemistry of serial sections with antibodies against Angptl2 and Mac2, a macrophage marker. We observed that abundant macrophages infiltrated the medial layer of aneurysmal lesions and that the Angptl2 staining pattern resembled that of Mac2 ( Figure 2F ), suggesting that in this model Angptl2-positive cells are macrophages. Furthermore, histological analyses based on Elastica van Gieson staining revealed thinning of the medial layer and disruption of the medial elastic lamellae in the treatment group on day 28, whereas those structures were preserved in the aorta of sham-operated animals at corresponding time points ( Figure 2G ).
To examine early stages of AAA formation in our model, we analyzed CaCl 2 -treated aortic vessel walls on day 7 after surgery, and observed statistically significant differences in the size of aortic dilatation between CaCl 2 -treated and shamoperated groups ( Figure 2H ). Expression of TNF-, IL-1, IL-6, and Angptl2 mRNAs was significantly increased in aortic lesions seen after CaCl 2 treatment compared with shamoperated animals ( Figure 2I ), indicating that inflammation occurs within the vessel wall by day 7 after surgery. At that time point, MMP-9 and MMP-2 expression and activity were significantly increased compared with sham-operated mice ( Figure 2J ), whereas histological analyses based on Elastica van Gieson staining revealed no disruption of medial elastic lamellae (data not shown). 
Angptl2 Loss Attenuates AAA Development in CaCl 2 -Induced Mouse Model
To determine how Angptl2 contributes to AAA development, we generated CaCl 2 -induced AAA in Angptl2 −/− mice. Overall, we observed no significant differences in abdominal aortic diameter baseline characteristics between Angptl2 −/− and wild-type mice (data not shown). On day 28 after CaCl 2 treatment, quantitative morphometric analyses showed that the aortic diameter of CaCl 2 -induced aneurysms was significantly decreased in mutant compared with wild-type mice ( Figure  3A ). We confirmed that there was no Angptl2 expression in aneurysmal lesions of AAA in Angptl2 −/− mice, whereas Angptl2 was abundantly expressed in AAA lesions from wildtype mice ( Figure II in the online-only Data Supplement). Histological analyses of wild-type mice on day 28 after CaCl 2 treatment showed degradation of the medial elastic lamellae, whereas the medial elastic lamellae were more intact in the aortic aneurysmal wall of Angptl2 −/− mice ( Figure 3B ), suggesting that Angptl2 loss attenuates CaCl 2 -induced AAA development. Expression of TNF-, IL-1, and IL-6 mRNAs in tissues from the aortic wall of CaCl 2 -treated Angptl2 −/− mice was markedly decreased compared with that seen in wild-type mice on day 7, a time corresponding with initiation of inflammation ( Figure 3C ). MMP-9 expression and activity in tissues from the aortic wall of CaCl 2 -treated Angptl2 −/− mice were significantly decreased compared with those seen in wild-type mice ( Figure 3D and 3E) . Taken together, these results indicate that Angptl2 loss decreases AAA formation by suppressing inflammation and ECM degradation in the vessel wall. On day 28 after surgery, we observed a similar pattern of Mac2positive infiltrating macrophages in aortic aneurysmal lesions of Angptl2 −/− and wild-type mice ( Figure 3F) , and observed no difference in expression of the macrophage-specific markers, CD68 and F4/80 ( Figure 3G ) and the macrophage chemotaxis factor, monocyte chemotactic protein 1 (MCP-1) ( Figure 3H ) in aneurysm tissues of both genotypes. These findings indicate that there is no difference in the number of infiltrating macrophages in aortic aneurysmal lesions between genotypes. Because Angptl2 is expressed in macrophages infiltrating an aortic aneurysmal lesion ( Figures 1E, 1F , and 2F), we conclude that macrophage-derived Angptl2 accelerates AAA development.
AAA Development Is Attenuated in Mice Transplanted With Angptl2 −/− BM
To determine whether macrophage-derived Angptl2 functions in AAA development, we analyzed the size of the CaCl 2induced AAA lesions in wild-type recipient mice that had undergone transplantation with either wild-type or Angptl2 −/− BM ( Figure 4A ). All recipient mice were irradiated before BM transplantation. On day 28 after CaCl 2 treatment, quantitative morphometric analyses showed that aortic diameters of CaCl 2 -induced aneurysms were significantly decreased in wild-type recipients that had received Angptl2 −/− compared with wild-type BM ( Figure 4B and 4C) . We next analyzed the size of the CaCl 2 -induced AAA lesions between Angptl2 −/− recipients transplanted with either wild-type or Angptl2 −/− BM ( Figure 1A) to confirm whether resident cell-derived Angptl2 contributes to AAA development. On day 28 after CaCl 2 treatment, quantitative morphometric analyses showed that aortic diameters of CaCl 2 -induced aneurysms were significantly increased in Angptl2 −/− recipients that had received wild-type compared with Angptl2 −/− BM ( Figure 4B and 4C) . These results indicate that Angptl2 from BM-derived macrophages infiltrating the AAA lesion likely enhances CaCl 2induced AAA development.
Angptl2 Induces Expression of Proinflammatory Cytokines and MMPs in Macrophages
Macrophages infiltrating AAA lesions are reportedly inflammatory macrophages. 21 Because our experiments suggest that macrophage-derived Angptl2 functions in CaCl 2 -induced AAA formation, we compared Angptl2 mRNA expression levels in inflammatory macrophages and noninflammatory resident macrophages. Thioglycollate-induced peritoneal macrophages are BM-derived inflammatory cells that produce proinflammatory cytokines, 22 suggesting that they resemble infiltrating macrophages in AAA. We found that thioglycollate-induced peritoneal macrophages showed markedly increased Angptl2 expression compared with noninduced peritoneal resident macrophages ( Figure 5A ), indicating that inflammatory activated macrophages are a significant source of Angptl2. We previously reported that Angptl2 signals to macrophages through integrin receptors 17 ; therefore, we hypothesized that macrophage-derived Angptl2 could alter expression levels of proinflammatory cytokines in macrophages in an autocrine manner. Significant decreases in TNF-, IL-1, and IL-6 expression were observed in thioglycollate-induced peritoneal macrophages from Angptl2 −/− mice compared with similarly treated wild-type mice ( Figure 5B ), suggesting that macrophage-derived Angptl2 promotes expression of proinflammatory cytokines in these cells. A hallmark of AAA is a localized, chronic inflammatory response accompanied by an MMP-induced proteolytic imbalance. 23 Increased proteolytic activity in inflammatory lesions promotes increased matrix turnover and progressive weakening of aortic walls. 24 When we examined MMP-9 expression and activity in thioglycollate-induced inflammatory peritoneal macrophages, we found that both were significantly decreased in Angptl2 −/− compared with wild-type macrophages ( Figure 5C and 5D ), suggesting that macrophage-derived Angptl2 promotes MMP-9 expression and activity in these cells. To confirm whether loss of an autocrine effect of Angptl2 alters expression of these factors, we evaluated the effect of adding exogenous Angptl2 to the culture medium of Angptl2 −/− macrophages. Angptl2 treatment increased expression of proinflammatory cytokines ( Figure  5E ) and MMP-9 ( Figure 5F ), suggesting that Angptl2 regulates macrophage expression of these factors in an autocrine manner.
Discussion
In the present study, we show that Angptl2 is abundantly expressed in infiltrating macrophages in aortic aneurysmal lesions of human patients with AAA and in those of a CaCl 2induced AAA mouse model. Furthermore, using a combination of in vivo experiments, in vitro cell culture experiments, and molecular genetic approaches, we found that Angptl2 is secreted by infiltrating macrophages in vessel walls of AAA tissue, and that macrophage-derived Angptl2 enhances inflammation and ECM degradation in those walls by enhancing expression of proinflammatory cytokines and MMPs in infiltrating macrophages, resulting in AAA development.
We recently reported that Angptl2 mediates various chronic inflammatory conditions, such as rheumatoid arthritis, dermatomyositis, cancer, and obesity-related metabolic disorder. [16] [17] [18] 25, 26 Thus, we hypothesized that Angptl2 functions in its associated inflammation in AAA development, which is accompanied by chronic inflammation of the vessel wall. Angptl2 −/− mice showed significantly attenuated AAA development associated with suppression of proinflammatory cytokine expression in the AAA wall, although we observed no difference in number of infiltrating macrophages between genotypes. Another pathology observed in AAA is structural destruction of the aneurysmal vessel wall through ECM degradation by MMPs, particularly MMP-9. 24, 27 Relative to phenotypes seen in wild-type mice, destructive remodeling of the vessel wall was attenuated when Angptl2 −/− mice were used to create a CaCl 2 -induced AAA mouse model, likely as a result of decreased MMP-9 expression in wall tissues. Many studies have identified a crucial role for MMPs in development of aortic aneurysms. 27, 28 Among MMPs, MMP-9, a gelatinolytic MMP derived mainly from macrophages, has received much attention as a pivotal destructive remodeling factor in both patients with AAA 29 and in an experimental AAA mouse model. 15 MMP-9 expression is reportedly regulated by the transcription factor nuclear factor-kappa B (NF-B), 30, 31 and nuclear factor B activation accelerates AAA development in experimental AAA models. 32, 33 Interestingly, we previously reported that Angptl2 activates the NF-B cascade by increasing inhibitor of kappa B (I) degradation, 16 suggesting that Angptl2 enhances MMP-9 expression in AAA development. Overall, our data suggest that Angptl2 increases expression of proinflammatory cytokines and MMP-9 by activating an NF-B-dependent cascade in infiltrating macrophages, which accelerates chronic inflammation and promotes destructive remodeling in the vessel wall, resulting in AAA progression.
MMPs are classically described in the context of ECM remodeling, which occurs in processes as diverse as tissue morphogenesis and wound healing. 34 In both cases, MMP activities are precisely regulated at the transcriptional level during normal tissue remodeling. On the other hand, MMP dysregulation occurs in various pathological conditions, such as rheumatoid arthritis, atherosclerosis, and tumor growth, invasion and metastasis, resulting in destructive tissue remodeling. 35 Our results here and elsewhere 17, 18 suggest that Angptl2 promotes MMP dysregulation and pathological tissue remodeling in numerous conditions including AAA. (1)) peritoneal macrophages. The ratio of Angptl2 expression levels in TGC(1) peritoneal macrophages relative to expression levels in TGC() peritoneal macrophages. Angptl2 expression level in TGC() peritoneal macrophages was set to 1. B and C, Expression levels of proinflammatory cytokines (B) and MMP-9 (C) in TGC-induced peritoneal macrophages from wild-type and Angptl2 −/− mice. Expression levels of these factors in macrophages from Angptl2 −/− mice are shown as a ratio of expression relative to that seen in wild-type mice. Expression levels in wild-type mice are set to 1. D, Upper photograph shows gelatin zymography representing MMP-9 activity in TGC-induced peritoneal macrophages from wild-type and Angptl2 −/− mice. Lower photograph shows quantitative analysis. Activity of MMP-9 in macrophages from Angptl2 −/− mice is shown as a ratio of activity relative to that seen in wild-type mice. Activity levels in wild-type mice are set to 1. E and F, Expression levels of proinflammatory cytokines (E) and MMP-9 (F) in TGC-induced Angptl2 −/− peritoneal macrophages after treatment with exogenous Angptl2. Expression levels of inflammatory cytokines and MMP-9 in macrophages after treatment with exogenous Angptl2 are shown as a ratio of expression relative to levels seen in macrophages without Angptl2 treatment. Expression levels of inflammatory cytokines and MMP-9 in macrophages without Angptl2 treatment were set to 1. Columns (A-F) represent mean valuesSEM (A, n4; B and C, n6; D, n5; E and F, n3). Data are normalized to -actin levels. *P0.05, **P0.01 compared with indicated controls. All experiments were performed at least 3.
Notably, we previously reported that expression of zebrafish Angptl2 (Zangptl2) is upregulated transiently at the site of fin regeneration in adult fish, 36 suggesting a beneficial function in tissue remodeling. Taken together, we speculate that perturbed or constitutive Angptl2 expression promotes detrimental tissue remodeling through chronic MMP activation and inflammation.
Clinical studies indicate a significant association between cigarette smoking and aortic aneurysm development, and that the duration of time smoked parallels elevated AAA risk. 2, 7, 37 Chronic smoke exposure is also associated with substantial increase in progression of aneurysmal dilatation in a mouse model. 38 Conversely, smoking cessation apparently reduces the growth rate of small AAAs in patients with AAA. 39 Interestingly, endothelial cells from internal mammary arteries of patients who are smokers reportedly exhibit higher Angptl2 expression than do cells from nonsmoker and former smoker patients, 40 suggesting that increased Angptl2 expression links cigarette smoking with AAA progression. We have also reported that Angptl2 expression is increased by hypoxia, undernutrition, and endoplasmic reticulum stress in adipocytes 16 and cancer cells. 26 Such microenvironmental changes are commonly observed in tissues from aneurysmal vessel walls, suggesting that they promote increased Angptl2 expression in numerous cell types.
In summary, our studies demonstrate that infiltrating macrophage-derived Angptl2 accelerates AAA progression by inducing chronic inflammation and ECM degradation in the aneurysmal vessel wall. These studies could suggest new therapeutic strategies to antagonize AAA progression.
